Actively Recruiting
Anticholinergics for Cervical Edema in Labor
Led by The University of Texas Health Science Center, Houston · Updated on 2026-05-06
200
Participants Needed
1
Research Sites
106 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to is to determine the clinical effectiveness of a single dose of intravenous (IV) medication for the prevention of labor arrest and cesarean delivery in primiparous women undergoing trial of labor.
CONDITIONS
Official Title
Anticholinergics for Cervical Edema in Labor
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Primiparous (first-time mother)
- Viable single intrauterine pregnancy
- At least 34 weeks of gestation
- Ruptured membranes
- Category I fetal heart tracing at time of inclusion
- Active phase of labor with cervix dilation of 6 cm or more
You will not qualify if you...
- Category II or III fetal heart tracing
- Allergy to intravenous Diphenhydramine
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
S
Samantha Antonioli, MD
CONTACT
A
Aaron Roberts
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here